# Trade Mark Journal No.2026/003 16 January 2026

## WO0000001875821 (1,5,44)

Office of origin: Switzerland

Date of International Registration:3 June 2025
Date of designation in the UK: 3 June 2025

International priority date claimed: 22 April 2025 (Switzerland) (831384)

Class 1
  Cells and chemical preparations for scientific research in the fields of immunotherapy and oncology.
Class 5
  Pharmaceutical preparations and biological preparations for the treatment of immune system related and oncological diseases and disorders; Biological diagnostic preparations for medical use.
Class 44
  Medical services, namely, modifying cells for the treatment of immune system related and oncological diseases and disorders; Immunotherapy treatments; medical diagnostic and treatment services; providing information in the field of oncology and immunotherapy treatments; providing medical information, consultancy and advisory services.

Iovance Biotherapeutics GmbH

Representative: Walder Wyss AG, Seefeldstrasse 123,, Postfach, CH-8034 Zürich, SWITZERLAND